Federal award
SYNERGENE THERAPEUTICS INC
HDTRA11310049
Assistance
Obligated and Ceiling
- Obligated (net)
- $5,083,968.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $5,083,968.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SYNERGENE THERAPEUTICS INC · W8E3G5851JK4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- Department of Defense · sub-agency 9761 · office HDTRA1
- Funding agency
- Department of Defense · sub-agency 9761
- Assistance listing (CFDA)
- CFDA 12.351
- FAIN
- HDTRA11310049
- Award type code
- 04
- Actions
- 18 · Sep 19, 2013 to Jun 5, 2018
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History18
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 5, 2018 | FY2018 | P00015 | B1 | $101,184.00 | — |
| Apr 4, 2018 | FY2018 | P00014 | B1 | $100,000.00 | — |
| Feb 27, 2018 | FY2018 | P00013 | B1 | $150,900.00 | — |
| Feb 5, 2018 | FY2018 | P00012 | B1 | $180,000.00 | — |
| Nov 29, 2017 | FY2018 | P00011 | B1 | $102,055.00 | — |
| Mar 21, 2017 | FY2017 | P00010 | B1 | $219,093.00 | — |
| Mar 2, 2017 | FY2017 | P00009 | B1 | $90,000.00 | — |
| Nov 7, 2016 | FY2017 | 0008 | EX | $99,998.00 | — |
| Jun 1, 2016 | FY2016 | 0008 | EX | $805,211.00 | — |
| Jun 1, 2016 | FY2016 | P00007 | B1 | $580,113.00 | — |
| Apr 13, 2016 | FY2016 | 0006 | B1 | $80,000.00 | — |
| Mar 15, 2016 | FY2016 | 0005 | B1 | $251,106.00 | — |
| Nov 18, 2015 | FY2016 | 0004 | B1 | $200,000.00 | — |
| Sep 7, 2015 | FY2015 | 0003 | EX | $148,615.00 | — |
| Jan 6, 2015 | FY2015 | 0002 | EX | $209,654.00 | — |
| Sep 8, 2014 | FY2014 | 0001 | EX | $605,813.00 | — |
| Sep 19, 2013 | FY2013 | — | A1 | $580,113.00 | — |
| Sep 19, 2013 | FY2013 | 0 | A1 | $580,113.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.